Shareholder's meeting of major pharmaceutical firms.

5 leading pharmaceutical firms having a fiscal year ended at Dec. 31 took a shareholder's meeting and reported their business strategies for the next fiscal year focusing on the salesmen's competence improvement and the business profitabilities enhancement, realizing the fact that the pharmaceutical economy this year looked very unclear.

Handok: Dividend payable 150 won in mid and 400 won a...